Cell stress proteins in atherothrombosis

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Madrigal Matute, Julio ^a   Martinez Pinna, Roxana ^a   Fernandez Garcia, Carlos Ernesto ^a   Ramos Mozo, Priscila ^a   Burillo, Elena ^a   Egido, Jesus ^a   Blanco Colio, Luis Miguel ^a   Martin Ventura, Jose Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL SIGNALING; CELLS; CYTOLOGY; DIAGNOSIS; ENZYME ACTIVITY;

CARDIO-VASCULAR DISEASE; CELL SIGNALLING; CELL STRESS; EXTRACELLULAR COMPARTMENTS; INFLAMMATORY RESPONSE; REACTIVE OXYGEN SPECIES; THIOREDOXINS; VASCULAR WALL;

PROTEINS;

PEROXIREDOXIN; THIOREDOXIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD VESSEL WALL; CELLULAR IMMUNITY; CIRCULATION; DISEASE MARKER; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; THROMBOSIS;

EID: 84864913489     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/232464     Document Type: Review

References (122)

1. Hemmingsen S. M., Woolford C., Van der Vies S. M., Tilly K., Dennis D. T., Georgopoulos C. P., Hendrix R. W., Ellis R. J., Homologous plant and bacterial proteins chaperone oligomeric protein assembly Nature 1988 333 6171 330 334
2. Madrigal-Matute J., Martin-Ventura J. L., Blanco-Colio L. M., Egido J., Michel J. B., Meilhac O., Heat-shock proteins in cardiovascular disease Advances in Clinical Chemistry 2011 54 1 43
3. Powis G., Briehl M., Oblong J., Redox signalling and the control of cell growth and death Pharmacology and Therapeutics 1995 68 1 149 173
4. Albertini R., Moratti R., De Luca G., Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies Current Molecular Medicine 2002 2 6 579 592 (Pubitemid 34982190)
5. Lavrovsky Y., Chatterjee B., Clark R. A., Roy A. K., Role of redox-regulated transcription factors in inflammation, aging and age-related diseases Experimental Gerontology 2000 35 5 521 532
6. World C. J., Yamawaki H., Berk B. C., Thioredoxin in the cardiovascular system Journal of Molecular Medicine 2006 84 12 997 1003
7. Holmgren A., Antioxidant function of thioredoxin and glutaredoxin systems Antioxidants and Redox Signaling 2000 2 4 811 820 (Pubitemid 32062330)
8. Powis G., Montfort W. R., Properties and biological activities of thioredoxins Annual Review of Biophysics Biomolecular Structure 2001 30 421 455 (Pubitemid 32566170)
9. Wood Z. A., Poole L. B., Karplus P. A., Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling Science 2003 300 5619 650 653 (Pubitemid 36520591)
10. Jeffery C. J., Moonlighting proteins Trends in Biochemical Sciences 1999 24 1 8 11 (Pubitemid 29074455)
11. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R., Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway Journal of Biological Chemistry 1992 267 34 24161 24164
12. Rhee S. G., Chae H. Z., Kim K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radical Biology and Medicine 2005 38 12 1543 1552 (Pubitemid 40726061)
13. Slaby I., Holmgren A., Thioredoxin reductase-dependent insulin disulfide reduction by phage T7 DNA polymerase reflects dissociation of the enzyme into subunits Journal of Biological Chemistry 1989 264 28 16502 16506 (Pubitemid 19243539)
14. World C., Spindel O. N., Berk B. C., Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor- : a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 8 1890 1897
15. Spielberger J. C., Moody A. D., Watson W. H., Oxidation and nuclear localization of thioredoxin-1 in sparse cell cultures Journal of Cellular Biochemistry 2008 104 5 1879 1889
16. Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J.., Cloning and expression of a novel mammalian thioredoxin Journal of Biological Chemistry 1997 272 5 2936 2941 (Pubitemid 27053344)
17. Tanaka T., Hosoi F., Yamaguchi-Iwai Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., Yodoi J., Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis EMBO Journal 2002 21 7 1695 1703 (Pubitemid 34614625)
18. Miranda-Vizuete A., Ljung J., Damdimopoulos A. E., Gustafsson J.., Oko R., Pelto-Huikko M., Spyrou G., Characterization of sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa Journal of Biological Chemistry 2001 276 34 31567 31574
19. Nakamura H., Nakamura K., Yodoi J., Redox regulation of cellular activation Annual Review of Immunology 1997 15 351 369 (Pubitemid 27169285)
20. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J., Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide Immunology Letters 1994 42 1-2 75 80 (Pubitemid 24305198)
21. Trigona W. L., Mullarky I. K., Cao Y., Sordillo L. M., Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells Biochemical Journal 2006 394 1 207 216 (Pubitemid 43259670)
22. Das K. C., Lewis-Molock Y., White C. W., Elevation of manganese superoxide dismutase gene expression by thioredoxin American Journal of Respiratory Cell and Molecular Biology 1997 17 6 713 726 (Pubitemid 127348662)
23. Zhang J., Li Y. D., Patel J. M., Block E. R., Thioredoxin overexpressin prevents NO-induced reduction of NO synthase activity in lung endothelial cells American Journal of Physiology, Lung Cellular and Molecular Physiology 1998 275 2 L288 L293
24. Shao L. E., Tanaka T., Gribi R., Yu J., Thioredoxin-related regulation of NO/NOS activities Annals of the New York Academy of Sciences 2002 962 140 150 (Pubitemid 34592308)
25. Haendeler J., Hoffmann J., Zeiher A. M., Dimmeler S., Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins Circulation 2004 110 7 856 861 (Pubitemid 39096015)
26. Junn E., Han S. H., Im J. Y., Yang Y., Cho E. W., Um H. D., Kim D. K., Lee K. W., Han P. L., Rhee S. G., Choi I., Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function Journal of Immunology 2000 164 12 6287 6295 (Pubitemid 30408809)
27. Matsui M., Oshima M., Oshima H., Takaku K., Maruyama T., Yodoi J., Taketo M. M., Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene Developmental Biology 1996 178 1 179 185 (Pubitemid 26297250)
28. Umekawa T., Sugiyama T., Kihira T., Murabayashi N., Zhang L., Nagao K., Kamimoto Y., Ma N., Yodoi J., Sagawa N., Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism Endocrinology 2008 149 8 3980 3988
29. Kamimoto Y., Sugiyama T., Kihira T., Zhang L., Murabayashi N., Umekawa T., Nagao K., Ma N., Toyoda N., Yodoi J., Sagawa N., Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy Diabetologia 2010 53 9 2046 2055
30. Hamada Y., Fujii H., Kitazawa R., Yodoi J., Kitazawa S., Fukagawa M., Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin- induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications Bone 2009 44 5 936 941
31. Kaimul Ahsan M., Nakamura H., Tanito M., Yamada K., Utsumi H., Yodoi J., Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt Free Radical Biology and Medicine 2005 39 12 1549 1559 (Pubitemid 41642586)
32. Zhou F., Gomi M., Fujimoto M., Hayase M., Marumo T., Masutani H., Yodoi J., Hashimoto N., Nozaki K., Takagi Y., Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia Brain Research 2009 1272 62 70
33. Wood Z. A., Schrder E., Harris J. R., Poole L. B., Structure, mechanism and regulation of peroxiredoxins Trends in Biochemical Sciences 2003 28 1 32 40 (Pubitemid 36051004)
34. Chae H. Z., Kim H. J., Kang S. W., Rhee S. G., Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin Diabetes Research and Clinical Practice 1999 45 2-3 101 112 (Pubitemid 29457756)
35. Rhee S. G., Woo H. A., Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H 2 O 2, and protein chaperones Antioxidants and Redox Signaling 2011 15 3 781 794
36. Peskin A. V., Low F. M., Paton L. N., Maghzal G. J., Hampton M. B., Winterbourn C. C., The high reactivity of peroxiredoxin 2 with H 2 O 2 is not reflected in its reaction with other oxidants and thiol reagents Journal of Biological Chemistry 2007 282 16 11885 11892 (Pubitemid 47100684)
37. Leavey P. J., Gonzalez-Aller C., Thurman G., Kleinberg M., Rinckel L., Ambruso D. W., Freeman S., Kuypers F. A., Ambruso D. R., A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity Journal of Biological Chemistry 2002 277 47 45181 45187 (Pubitemid 36159121)
38. Uwayama J., Hirayama A., Yanagawa T., Warabi E., Sugimoto R., Itoh K., Yamamoto M., Yoshida H., Koyama A., Ishii T., Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals Biochemical and Biophysical Research Communications 2006 339 1 226 231 (Pubitemid 41697539)
39. Fang J., Nakamura T., Cho D. H., Gu Z., Lipton S. A., S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18742 18747 (Pubitemid 350210767)
40. Chae H. Z., Oubrahim H., Park J. W., Rhee S. G., Chock P. B., Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidases that function as antioxidants, molecular chaperones, and signal modulators Antioxidants Redox Signaling 2012 16 6 506 523
41. Yang K. S., Kang S. W., Woo H. A., Hwang S. C., Chae H. Z., Kim K., Rhee S. G., Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid Journal of Biological Chemistry 2002 277 41 38029 38036 (Pubitemid 35154654)
42. Barranco-Medina S., Lzaro J. J., Dietz K. J., The oligomeric conformation of peroxiredoxins links redox state to function FEBS Letters 2009 583 12 1809 1816
43. Lim J. C., Choi H. I., Park Y. S., Nam H. W., Woo H. A., Kwon K. S., Kim Y. S., Rhee S. G., Kim K., Chae H. Z., Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity Journal of Biological Chemistry 2008 283 43 28873 28880
44. Rhee S. G., Jeong W., Chang T. S., Woo H. A., Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance Kidney international. Supplement 2007 106 S3 S8
45. Neumann C. A., Krause D. S., Carman C. V., Das S., Dubey D. P., Abraham J. L., Bronson R. T., Fujiwara Y., Orkin S. H., Van Etten R. A., Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression Nature 2003 424 6948 561 565 (Pubitemid 36975778)
46. Lee T. H., Kim S. U., Yu S. L., Kim S. H., Park D. S., Moon H. B., Dho S. H., Kwon K. S., Kwon H. J., Han Y. H., Jeong S., Kang S. W., Shin H. S., Lee K. K., Rhee S. G., Yu D. Y., Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice Blood 2003 101 12 5033 5038 (Pubitemid 36857770)
47. Agrawal-Singh S., Isken F., Agelopoulos K., Klein H.-U., Thoennissen N. H., Koehler G., Hascher A., Bumer N., Berdel W. E., Thiede C., Ehninger G., Becker A., Schlenke P., Wang Y., McClelland M., Krug U., Koschmieder S., Bchner T., Yu D.-Y., Singh S. V., Hansen K., Serve H., Dugas M., Mller-Tidow C., Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene Blood 2012 119 10 2346 2357
48. Li L., Shoji W., Takano H., Nishimura N., Aoki Y., Takahashi R., Goto S., Kaifu T., Takai T., Obinata M., Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress Biochemical and Biophysical Research Communications 2007 355 3 715 721 (Pubitemid 46330210)
49. Cox A. G., Winterbourn C. C., Hampton M. B., Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling Biochemical Journal 2010 425 2 313 325
50. Chang T. S., Cho C. S., Park S., Yu S., Sang W. K., Sue G. R., Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria Journal of Biological Chemistry 2004 279 40 41975 41984 (Pubitemid 39313648)
51. Huh J. Y., Kim Y., Jeong J., Park J., Kim I., Huh K. H., Kim Y. S., Woo H. A., Rhee S. G., Lee K. J., Ha H., Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression Antioxidants Redox Signaling 2012 16 3 229 243
52. Iuchi Y., Okada F., Tsunoda S., Kibe N., Shirasawa N., Ikawa M., Okabe M., Ikeda Y., Fujii J., Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress Biochemical Journal 2009 419 1 149 158
53. Zhou Y., Kok K. H., Chun A. C. S., Wong C. M., Wu H. W., Lin M. C. M., Fung P. C. W., Kung H. F., Jin D. Y., Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis Biochemical and Biophysical Research Communications 2000 268 3 921 927 (Pubitemid 30150892)
54. Nagy N., Malik G., Fisher A. B., Das D. K., Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury American Journal of Physiology, Heart and Circulatory Physiology 2006 291 6 H2636 H2640
55. Manevich Y., Fisher A. B., Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism Free Radical Biology and Medicine 2005 38 11 1422 1432 (Pubitemid 40693827)
56. Azevedo L. C. P., Pedro M. A., Laurindo F. R. M., Circulating microparticles as therapeutic targets in cardiovascular diseases Recent Patents on Cardiovascular Drug Discovery 2007 2 1 41 51 (Pubitemid 46813415)
57. Buschow S. I., Van Balkom B. W. M., Aalberts M., Heck A. J. R., Wauben M., Stoorvogel W., MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis Immunology and Cell Biology 2010 88 8 851 856
58. Welton J. L., Khanna S., Giles P. J., Brennan P., Brewis I. A., Staffurth J., Mason M. D., Clayton A., Proteomics analysis of bladder cancer exosomes Molecular and Cellular Proteomics 2010 9 6 1324 1338
59. Choi D. S., Lee J. M., Gun W. P., Lim H. W., Joo Y. B., Kim Y. K., Kwon K. H., Ho J. K., Kwang P. K., Yong S. G., Proteomic analysis of microvesicles derived from human colorectal cancer cells Journal of Proteome Research 2007 6 12 4646 4655
60. Gonzales P. A., Pisitkun T., Hoffert J. D., Tchapyjnikov D., Star R. A., Kleta R., Wang N. S., Knepper M. A., Large-scale proteomics and phosphoproteomics of urinary exosomes Journal of the American Society of Nephrology 2009 20 2 363 379
61. Dessein A. J., Lenzi H. L., Bina J. C., Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni Cellular Immunology 1984 85 1 100 113 (Pubitemid 14138983)
62. Pekkari K., Gurunath R., Arner E. S. J., Holmgren A., Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma Journal of Biological Chemistry 2000 275 48 37474 37480 (Pubitemid 32004854)
63. Pekkari K., Avila-Carino J., Bengtsson A., Gurunath R., Scheynius A., Holmgren A., Truncated thioredoxin. (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes Blood 2001 97 10 3184 3190
64. Kondo N., Ishii Y., Kwon Y. W., Tanito M., Horita H., Nishinaka Y., Nakamura H., Yodoi J., Redox-sensing release of human thioredoxin from t lymphocytes with negative feedback loops Journal of Immunology 2004 172 1 442 448 (Pubitemid 38020499)
65. Jikimoto T., Nishikubo Y., Koshiba M., Kanagawa S., Morinobu S., Morinobu A., Saura R., Mizuno K., Kondo S., Toyokuni S., Nakamura H., Yodoi J., Kumagai S., Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis Molecular Immunology 2002 38 10 765 772 (Pubitemid 34158879)
66. Leaver S. K., MacCallum N. S., Pingle V., Hacking M. B., Quinlan G. J., Evans T. W., Burke-Gaffney A., Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor Intensive Care Medicine 2010 36 2 336 341
67. Mowbray A. L., Kang D. H., Sue G. R., Sang W. K., Jo H., Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant Journal of Biological Chemistry 2008 283 3 1622 1627
68. Lehel C., Olh Z., Petrovics G., Jakab G., Anderson W. B., Influence of various domains of protein kinase C on its PMA-induced translocation from the golgi to the plasma membrane Biochemical and Biophysical Research Communications 1996 223 1 98 103
69. Ambruso D. R., Ellison M. A., Thurman G. W., Leto T. L., Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity Biochimica et Biophysica Acta 2012 1823 2 306 315
70. Chang J. W., Lee S. H., Lu Y., Yoo Y. J., Transforming growth factor- 1 induces the non-classical secretion of peroxiredoxin-I in A549 cells Biochemical and Biophysical Research Communications 2006 345 1 118 123
71. Jong W. C., Seung H. L., Ju Y. J., Ho Z. C., Young C. K., Park Z. Y., Yung J. Y., Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer FEBS Letters 2005 579 13 2873 2877 (Pubitemid 40725260)
72. Yoshida S., Katoh T., Tetsuka T., Uno K., Matsui N., Okamoto T., Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF- -induced production of IL-6 and IL-8 from cultured synovial fibroblasts Journal of Immunology 1999 163 1 351 358 (Pubitemid 29295860)
73. Hunter-Lavin C., Davies E. L., Bacelar M. M. F. V. G., Marshall M. J., Andrew S. M., Williams J. H. H., Hsp70 release from peripheral blood mononuclear cells Biochemical and Biophysical Research Communications 2004 324 2 511 517 (Pubitemid 39345547)
74. Asea A., Rehli M., Kabingu E., Boch J. A., Baré O., Auron P. E., Stevenson M. A., Calderwood S. K., Novel signal transduction pathway utilized by extracellular HSP70. Role of toll-like receptor (TLR) 2 and TLR4 Journal of Biological Chemistry 2002 277 17 15028 15034 (Pubitemid 34952579)
75. Lotze M. T., Zeh H. J., Rubartelli A., Sparvero L. J., Amoscato A. A., Washburn N. R., DeVera M. E., Liang X., Tr M., Billiar T., The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity Immunological Reviews 2007 220 1 60 81 (Pubitemid 350045579)
76. Westermann P., Knoblich M., Maier O., Lindschau C., Haller H., Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles Biochemical Journal 1996 320 2 651 658 (Pubitemid 26417793)
77. Staubach S., Razawi H., Hanisch F. G., Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7 Proteomics 2009 9 10 2820 2835
78. Admyre C., Johansson S. M., Qazi K. R., Filén J. J., Lahesmaa R., Norman M., Neve E. P. A., Scheynius A., Gabrielsson S., Exosomes with immune modulatory features are present in human breast milk Journal of Immunology 2007 179 3 1969 1978
79. Gonzalez-Begne M., Lu B., Han X., Hagen F. K., Hand A. R., Melvin J. E., Yates J. R., Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT) Journal of Proteome Research 2009 8 3 1304 1314
80. Harrison D., Griendling K. K., Landmesser U., Hornig B., Drexler H., Role of oxidative stress in atherosclerosis American Journal of Cardiology 2003 91 3 A7 A11
81. Lu Y., Wahl L. M., Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF- B activity in lipopolysaccharide-activated human primary monocytes Journal of Immunology 2005 175 8 5423 5429 (Pubitemid 41456428)
82. Blumberg J., Use of biomarkers of oxidative stress in research studies Journal of Nutrition 2004 134 11 3188S 3189S (Pubitemid 39470110)
83. Virmani R., Burke A. P., Farb A., Kolodgie F. D., Pathology of the Vulnerable Plaque Journal of the American College of Cardiology 2006 47 8, supplement C13 C18
84. Jo H., Song H., Mowbray A., Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis Antioxidants and Redox Signaling 2006 8 9-10 1609 1619 (Pubitemid 44726335)
85. Qu A., Jiang C., Xu M., Zhang Y., Zhu Y., Xu Q., Zhang C., Wang X., PGC-1 attenuates neointimal formation via inhibition of vascular smooth muscle cell migration in the injured rat carotid artery American Journal of Physiology, Cell Physiology 2009 297 3 C645 C653
86. Popowich D. A., Vavra A. K., Walsh C. P., Bhikhapurwala H. A., Rossi N. B., Jiang Q., Aalami O. O., Kibbe M. R., Regulation of reactive oxygen species by p53: implications for nitric oxide-mediated apoptosis American Journal of Physiology, Heart and Circulatory Physiology 2010 298 6 H2192 H2200
87. Sahaf B., Rosén A., Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes Antioxidants and Redox Signaling 2000 2 4 717 726 (Pubitemid 32062323)
88. Hess A., Wijayanti N., Neuschfer-Rube A. P., Katz N., Kietzmann T., Immenschuh S., Phorbol ester-dependent activation of peroxiredoxin i gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway Journal of Biological Chemistry 2003 278 46 45419 45434 (Pubitemid 37432680)
89. Cha M. K., Kim I. H., Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell Biochemical and Biophysical Research Communications 1995 217 3 900 907
90. Martinez-Pinna R., Ramos-Mozo P., Madrigal-Matute J., Blanco-Colio L. M., Lopez J. A., Calvo E., Camafeita E., Lindholt J. S., Meilhac O., Delbosc S., Michel J. B., De Ceniga M. V., Egido J., Martin-Ventura J. L., Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 4 935 943
91. Martinez-Pinna R., Lindholt J. S., Blanco-Colio L. M., Dejouvencel T., Madrigal-Matute J., Ramos-Mozo P., Vega de Ceniga M., Michel J. B., Egido J., Meilhac O., Martin-Ventura J. L., Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution Atherosclerosis 2010 212 1 333 338
92. Okuda M., Inoue N., Azumi H., Seno T., Sumi Y., Hirata K. I., Kawashima S., Hayashi Y., Itoh H., Yodoi J., Yokoyama M., Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 9 1483 1487 (Pubitemid 34219812)
93. Takagi Y., Gon Y., Todaka T., Nozaki K., Nishiyama A., Sono H., Hashimoto N., Kikuchi H., Yodoi J., Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries Laboratory Investigation 1998 78 8 957 966 (Pubitemid 28378210)
94. Nishihira K., Yamashita A., Imamura T., Hatakeyama K., Sato Y., Nakamura H., Yodoi J., Ogawa H., Kitamura K., Asada Y., Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage Atherosclerosis 2008 201 2 360 367
95. Furman C., Rundlf A. K., Larigauderie G., Jaye M., Bricca G., Copin C., Kandoussi A. M., Fruchart J. C., Arnér E. S. J., Rouis M., Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins Free Radical Biology and Medicine 2004 37 1 71 85 (Pubitemid 38746652)
96. Turoczi T., Chang V. W. H., Engelman R. M., Maulik N., Ho Y. S., Das D. K., Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1 Journal of Molecular and Cellular Cardiology 2003 35 6 695 704 (Pubitemid 36677453)
97. Samuel S. M., Thirunavukkarasu M., Penumathsa S. V., Koneru S., Zhan L., Maulik G., Sudhakaran P. R., Maulik N., Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats Circulation 2010 121 10 1244 1255
98. Adluri R. S., Thirunavukkarasu M., Zhan L., Akita Y., Samuel S. M., Otani H., Ho Y. S., Maulik G., Maulik N., Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice Journal of Molecular and Cellular Cardiology 2011 50 1 239 247
99. Yamamoto M., Yang G., Hong C., Liu J., Holle E., Yu X., Wagner T., Vatner S. F., Sadoshima J., Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy Journal of Clinical Investigation 2003 112 9 1395 1406 (Pubitemid 38057693)
100. Yang Y., Ago T., Zhai P., Abdellatif M., Sadoshima J., Thioredoxin 1 negatively regulates angiotensin II-Induced cardiac hypertrophy through upregulation of miR-98/let-7 Circulation Research 2011 108 3 305 313
101. Yoshioka J., Schulze P. C., Cupesi M., Sylvan J. D., MacGillivray C., Gannon J., Huang H., Lee R. T., Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity Circulation 2004 109 21 2581 2586 (Pubitemid 38720560)
102. Lowenstein C. J., Exogenous thioredoxin reduces inflammation in autoimmune myocarditis Circulation 2004 110 10 1178 1179 (Pubitemid 39202328)
103. Billiet L., Furman C., Larigauderie G., Copin C., Brand K., Fruchart J. C., Rouis M., Extracellular human thioredoxin-1 inhibits lipopolysaccharide- induced interleukin-1 expression in human monocyte-derived macrophages Journal of Biological Chemistry 2005 280 48 40310 40318 (Pubitemid 41779168)
104. Liu W., Nakamura H., Shioji K., Tanito M., Oka S. I., Ahsan M. K., Son A., Ishii Y., Kishimoto C., Yodoi J., Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice Circulation 2004 110 10 1276 1283 (Pubitemid 39202345)
105. Aota M., Matsuda K., Isowa N., Wada H., Yodoi J., Ban T., Protection against reperfusion-induced arrhythmias by human thioredoxin Journal of Cardiovascular Pharmacology 1996 27 5 727 732 (Pubitemid 26134250)
106. Hattori I., Takagi Y., Nakamura H., Nozaki K., Bai J., Kondo N., Sugino T., Nishimura M., Hashimoto N., Yodoi J., Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice Antioxidants and Redox Signaling 2004 6 1 81 87 (Pubitemid 38063978)
107. Koneru S., Penumathsa S. V., Thirunavukkarasu M., Zhan L., Maulik N., Thioredoxin-1 gene delivery induces heme oxygenase-1 mediated myocardial preservation after chronic infarction in hypertensive rats American Journal of Hypertension 2009 22 2 183 190
108. Miyamoto S., Sakamoto T., Soejima H., Shimomura H., Kajiwara I., Kojima S., Hokamaki J., Sugiyama S., Yoshimura M., Ozaki Y., Nakamura H., Yodoi J., Ogawa H., Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction American Heart Journal 2003 146 3 465 471 (Pubitemid 37083080)
109. Hokamaki J., Kawano H., Soejima H., Miyamoto S., Kajiwara I., Kojima S., Sakamoto T., Sugiyama S., Yoshimura M., Nakamura H., Yodoi J., Ogawa H., Plasma thioredoxin levels in patients with unstable angina International Journal of Cardiology 2005 99 2 225 231 (Pubitemid 40320794)
110. Wu Y., Yang L., Zhong L., Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity Atherosclerosis 2010 212 1 351 355
111. Wahlgren C. M., Pekkari K., Elevated thioredoxin after angioplasty in peripheral arterial disease European Journal of Vascular and Endovascular Surgery 2005 29 3 281 286 (Pubitemid 40267968)
112. Wijayanti N., Naidu S., Kietzmann T., Immenschuh S., Inhibition of phorbol ester-dependent peroxiredoxin I gene activation by lipopolysaccharide via phosphorylation of RelA/p65 at serine 276 in monocytes Free Radical Biology and Medicine 2008 44 4 699 710
113. Choi M. H., Lee I. K., Kim G. W., Kim B. U., Han Y. H., Yu D. Y., Park H. S., Kim K. Y., Lee J. S., Choi C., Bae Y. S., Lee B. I., Rhee S. G., Kang S. W., Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II Nature 2005 435 7040 347 353 (Pubitemid 40745544)
114. Rhee S. G., Kang S. W., Jeong W., Chang T. S., Yang K. S., Woo H. A., Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins Current Opinion in Cell Biology 2005 17 2 183 189 (Pubitemid 40380942)
115. Ihida-Stansbury K., McKean D. M., Gebb S. A., Martin J. F., Stevens T., Nemenoff R., Vaughn J., Lane K., Loyd J., Wheeler L., Morrell N. W., Ivy D., Jones P. L., Regulation and functions of the paired-related homeobox gene PRX1 in pulmonary vascular development and disease Chest 2005 128 6, supplement S591
116. Kisucka J., Chauhan A. K., Patten I. S., Yesilaltay A., Neumann C., Van Etten R. A., Krieger M., Wagner D. D., Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis Circulation Research 2008 103 6 598 605
117. Park J.-G., Yoo J.-Y., Jeong S.-J., Choi J.-H., Lee M.-R., Lee M.-N., Hwa Lee J., Kim H. C., Jo H., Yu D.-Y., Kang S. W., Rhee S. G., Lee M.-H., Oh G. T., Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice Circulation Research 2011 109 7 739 749
118. Kang S. W., Rhee S. G., Chang T. S., Jeong W., Choi M. H., 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications Trends in Molecular Medicine 2005 11 12 571 578 (Pubitemid 41713999)
119. Li W., Febbraio M., Reddy S. P., Yu D. Y., Yamamoto M., Silverstein R. L., CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs Journal of Clinical Investigation 2010 120 11 3996 4006
120. Urbonavicius S., Lindholt J. S., Vorum H., Urbonaviciene G., Henneberg E. W., Honoré B., Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms Journal of Vascular Surgery 2009 49 2 455 463
121. Miller F. J. Jr., Sharp W. J., Fang X., Oberley L. W., Oberley T. D., Weintraub N. L., Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 4 560 565 (Pubitemid 34408734)
122. Matsushima S., Ide T., Yamato M., Matsusaka H., Hattori F., Ikeuchi M., Kubota T., Sunagawa K., Hasegawa Y., Kurihara T., Oikawa S., Kinugawa S., Tsutsui H., Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice Circulation 2006 113 14 1779 1786 (Pubitemid 43958471)